The relationship in between infection and conventional antibiotics

Could CBD work in the fight against resistant bacterial strains? The results from the University of Queensland in Australia suggest that it is possible. But before analyzing the research study in depth, it is useful to comprehend the evolution of the relationship in between bacteria and antibiotics.

Given that the innovative discovery of penicillin by Alexander Fleming in 1928, antibiotics have been a vital tool in the fight against bacteria and infections. And although we still utilize the exact same tested methods today, bacteria have progressed. When exposed to antibiotics, particular bacteria, fungi and parasites are able to adapt and cancel the effectiveness of the drug by developing resistance.

It’s worth mentioning that antimicrobial resistance was most likely to occur anyhow, as the genetic code for bacteria modifications with time. However, it is believed that the overuse of antibiotics is an important factor that speeds up the advancement of resistant strains.

According to the World Health Organization, antimicrobial resistance “is a significantly major risk to worldwide public health that requires action in all sectors of government and in society.” This has actually led scientists to believe outside package by attempting to recognize compounds that could be helpful in the fight against harmful bacteria. Among these compounds is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Scientists are looking for brand-new ways to attack infections and resistant bacteria.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD is effective against Gram-positive bacteria. Pressures of Gram-positive bacteria consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia). New Earth CBD  had some great quality CBD brands.

Dr. Blaskovich provided his findings at a yearly conference of the American Society for Microbiology. In vitro samples of both types of gram-positive bacteria were treated with synthetic CBD. The results led Dr. Blaskovich to the conclusion that CBD operates at levels comparable to those of prescription antibiotics vancomycin and daptomycin. He likewise discovered that CBD appeared to work against gram-positive strains of resistant bacteria, which many standard antibiotics are starting to fail.

” In specific, the activity was selected against the resistant strains of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to cause resistance and was active against MRSA biofilms. “

The team likewise carried out another research study utilizing topical CBD to treat a skin infection in mice. Once again, although the results were positive, CBD did not appear to get rid of the infection, but just to reduce the variety of bacterial cells.

Could CBD become an antibiotic?

While it is easy to hail this work as a substantial advancement in the antibacterial capabilities of CBD, it is too soon to quit on penicillin.

Although it is believed that the effectiveness of CBD might come from the method it assaults the biofilm surrounding bacterial cells, the authors are still not sure of the mechanism of action of CBD. They likewise did not hesitate to point out the shortcomings of the research study. Dr. Blaskovich explained that because the results are in the preliminary stages, it is far too early for individuals to begin treating their CBD infections themselves.

The research study was likewise carried out in vitro (outside the human body), and there is a threat that the results of medical trials will not be the same. Several compounds have revealed antibacterial efficacy in petri meals, but then stopped working at this vital stage. It ought to likewise be mentioned that the two studies were performed in collaboration with Botanix Pharmaceuticals Ltd, a pharmaceutical company focusing on topical CBD products – see Midnight CBD for some great products.

However, this research study could be an important step forward for CBD and the fight against antimicrobial resistance. CBD continues to have a good safety profile and is not considered harmful even in big amounts. Luckily, Dr. Blaskovich and his team strategy to continue their research study.

Scroll to top